Man-Hui Pai1, Cing-Syuan Lei2, Shiau-Tsz Su2, Sung-Ling Yeh2, Yu-Chen Hou3,4. 1. Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. 2. School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, Taiwan. 3. Master Program in Food Safety, College of Nutrition, Taipei Medical University, 250 Wu-Hsing Street, Taipei, 11031, Taiwan. ychou@tmu.edu.tw. 4. Nutrition Research Center, Taipei Medical University Hospital, Taipei, Taiwan. ychou@tmu.edu.tw.
Abstract
PURPOSE: Diabetes is a chronic inflammatory disorder resulting in endothelial dysfunction which contributes to peripheral arterial disease and limb ischemia. Leukocytes play critical roles in vascular and tissue remodelling after ischemia. This study investigated the effects of dietary glutamine (GLN) supplementation on immune cell polarization in diabetic mice subjected to limb ischemia. METHODS: Diabetes was induced by an intraperitoneal injection of streptozotocin for 5 consecutive days in C57BL/6J mice. Diabetic mice were fed the AIN-93 diet or an AIN-93 diet in which a part of the casein was replaced by GLN. After 3 weeks of the dietary intervention, mice were subjected to unilateral femoral artery ligation to induce limb ischemia. RESULTS: GLN supplementation enhanced the proportion of anti-inflammatory monocytes and regulatory T cells in the blood. Expression of C-C motif chemokine receptor 5 by activated CD4+ T cells was promoted and prolonged in the GLN-supplemented group. GLN downregulated the percentage of M1 macrophages in muscle tissues which was correlated with lower levels of C-C motif chemokine ligand 2 in plasma. The muscle M1/M2 ratio was also reduced in the GLN group. Gene expression of interleukin-6 was suppressed by GLN supplementation, while expression levels of the peroxisome proliferator-activated receptor γ and myogenic differentiation 1 genes were elevated in post-ischemic muscles. Histological findings also indicated that muscle regeneration was accelerated in the GLN group. CONCLUSIONS: GLN supplementation in diabetic mice may exert more-balanced polarization of CD4+ T cells, monocytes, and macrophages, thus attenuating inflammatory responses and contributing to muscle regeneration after limb ischemia.
PURPOSE:Diabetes is a chronic inflammatory disorder resulting in endothelial dysfunction which contributes to peripheral arterial disease and limb ischemia. Leukocytes play critical roles in vascular and tissue remodelling after ischemia. This study investigated the effects of dietary glutamine (GLN) supplementation on immune cell polarization in diabeticmice subjected to limb ischemia. METHODS:Diabetes was induced by an intraperitoneal injection of streptozotocin for 5 consecutive days in C57BL/6J mice. Diabeticmice were fed the AIN-93 diet or an AIN-93 diet in which a part of the casein was replaced by GLN. After 3 weeks of the dietary intervention, mice were subjected to unilateral femoral artery ligation to induce limb ischemia. RESULTS:GLN supplementation enhanced the proportion of anti-inflammatory monocytes and regulatory T cells in the blood. Expression of C-C motif chemokine receptor 5 by activated CD4+ T cells was promoted and prolonged in the GLN-supplemented group. GLN downregulated the percentage of M1 macrophages in muscle tissues which was correlated with lower levels of C-C motif chemokine ligand 2 in plasma. The muscle M1/M2 ratio was also reduced in the GLN group. Gene expression of interleukin-6 was suppressed by GLN supplementation, while expression levels of the peroxisome proliferator-activated receptor γ and myogenic differentiation 1 genes were elevated in post-ischemic muscles. Histological findings also indicated that muscle regeneration was accelerated in the GLN group. CONCLUSIONS:GLN supplementation in diabeticmice may exert more-balanced polarization of CD4+ T cells, monocytes, and macrophages, thus attenuating inflammatory responses and contributing to muscle regeneration after limb ischemia.
Authors: Abhishek K Jha; Stanley Ching-Cheng Huang; Alexey Sergushichev; Vicky Lampropoulou; Yulia Ivanova; Ekaterina Loginicheva; Karina Chmielewski; Kelly M Stewart; Juliet Ashall; Bart Everts; Edward J Pearce; Edward M Driggers; Maxim N Artyomov Journal: Immunity Date: 2015-03-17 Impact factor: 31.745
Authors: Bjoern A Menge; Henning Schrader; Peter R Ritter; Mark Ellrichmann; Waldemar Uhl; Wolfgang E Schmidt; Juris J Meier Journal: Regul Pept Date: 2009-08-18
Authors: Yosuke Kayama; Uwe Raaz; Ann Jagger; Matti Adam; Isabel N Schellinger; Masaya Sakamoto; Hirofumi Suzuki; Kensuke Toyama; Joshua M Spin; Philip S Tsao Journal: Int J Mol Sci Date: 2015-10-23 Impact factor: 5.923
Authors: Tatiana E Koike; Rodrigo A Dell Aquila; Kellana S Silva; Marcelo S Aoki; Elen H Miyabara Journal: J Muscle Res Cell Motil Date: 2022-02-24 Impact factor: 3.352